Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | FUT7 | Q11130 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5075273 | 0.98 | LMNA (0.40) | LMNAFUT7TP53BLM | |
| SCHEMBL5076464 | 0.92 | LMNA (0.38) | LMNABLMMEN1ALDH1A1HTT | |
| SCHEMBL5075757 | 0.81 | — | — | |
| SCHEMBL28939095 | 0.79 | LMNA (0.46) | LMNAFUT7TP53BLMMEN1 | |
| SCHEMBL15293795 | 0.77 | LMNA (0.43) | LMNAFUT7TP53BLMMEN1 | |
| SCHEMBL28470985 | 0.77 | LMNA (0.43) | LMNAFUT7TP53BLM | |
| SCHEMBL8810649 | 0.77 | LMNA (0.43) | LMNAFUT7TP53BLMMEN1 | |
| SCHEMBL5079818 | 0.75 | LMNA (0.42) | LMNAFUT7TP53BLMMEN1 | |
| SCHEMBL439762 | 0.75 | LMNA (0.42) | LMNAFUT7TP53BLMALDH1A1 | |
| SCHEMBL5637565 | 0.75 | APP (0.44) | LMNAFUT7TP53BLMMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1413572-B1 | PROCESS FOR PRODUCING ACID ANHYDRIDE | TOKUYAMA CORP (JP) | 2008-10-08 | — | — | EP | disclosed |
| US-7220881-B2 | Process for production of acid anhydride | TOKUYAMA CORPORATION (JP) | 2007-05-22 | — | — | US | disclosed |
| CN-1220676-C | Method for producing acid anhydride | TOKUYAMA CORP (JP) | 2005-09-28 | — | — | CN | disclosed |
| US-20040242929-A1 | Process for production of acid anhydride | TOKUYAMA CORPORATION (JP) | 2004-12-02 | — | — | US | disclosed |
| CN-1537097-A | Method for producing acid anhydride | ��ʽ�����ɽ | 2004-10-13 | — | — | CN | disclosed |
| EP-1413572-A1 | PROCESS FOR PRODUCING ACID ANHYDRIDE | Tokuyama Corporation (JP) | 2004-04-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040242929-A1 | Process for production of acid anhydride | CA4, CA9, CA6 | LMNA 3774/4885FUT7 1101/4885TP53 4087/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.